PanTheryx Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 45
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 10
  • Investments
  • 4

PanTheryx General Information

Description

Provider of intestinal research and medical nutrition products intended to address serious gastrointestinal microbiome-related health conditions. The company is focused on pharmaceutical research, development and commercialization of products that target the gastrointestinal microbiome, enabling pharmaceutical and consumer healthcare companies to deliver safe and efficient anti-diarrhea medicine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 4845 Pearl East Circle
  • Suite 101
  • Boulder, CO 80301
  • United States
+1 (602) 000-0000

PanTheryx Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PanTheryx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PanTheryx‘s full profile, request access.

Request a free trial

PanTheryx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of intestinal research and medical nutrition products intended to address serious gastrointestinal microbiome-r
Drug Discovery
Boulder, CO
45 As of 2021
00000
0000000 0000 00000

00000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
000000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

0000000

eprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat
000000000000000
The Woodlands, TX
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PanTheryx Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ironwood Pharmaceuticals Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
0000000 0000000000 Corporation The Woodlands, TX 00 00000 000000000 00000
00 000000 Corporation Leeds, United Kingdom 000 00000 000000000000 00000
00000000 Formerly VC-backed Cambridge, MA 00 00000 00000000000 00000
0000000 Corporation Blackburn North, Australia 0 000.00 000000000 000.00
You’re viewing 5 of 45 competitors. Get the full list »

PanTheryx Patents

PanTheryx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200323954-A1 Methods and compositions for reducing gut ischemia/reperfusion-induced injury Abandoned 10-Apr-2019 00000000000
ES-2742734-T3 Compositions and procedures for treatment in clinical applications of general spectrum, not differentiated or mixed Active 23-Nov-2010 000000000
AU-2018203497-B2 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications Active 23-Nov-2010 000000000
AU-2018203497-A1 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications Granted 23-Nov-2010 000000000
AU-2016201651-B2 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications Active 23-Nov-2010 C07K16/10
To view PanTheryx’s complete patent history, request access »

PanTheryx Executive Team (12)

Name Title Board Seat Contact Info
Wes Parris Chief Executive Officer, President and Board Member
Tom Feeley Chief Financial Officer
Amy Gibbs Controller
George Stagnitti Executive Vice President, Research & Development
Bimla Starzl Co-Founder
You’re viewing 5 of 12 executive team members. Get the full list »

PanTheryx Board Members (11)

Name Representing Role Since
00000 00000 00 Pegasus Capital Advisors Vice Chairman 000 0000
00000 00000000 00 PanTheryx Chairman 000 0000
00000 00000 Pegasus Capital Advisors Board Member 000 0000
000000 00000000 PanTheryx Board Member 000 0000
000000 00 00 PanTheryx Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

PanTheryx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PanTheryx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PanTheryx‘s full profile, request access.

Request a free trial

PanTheryx Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 28-Feb-2021 0000000000 Other Consumer Non-Durables 000 00000
0000000000000 14-Oct-2020 0000000000 Biotechnology 000 00000
000 00000000 14-Feb-2017 0000000000 Other Pharmaceuticals and Biotechnology 0000 0000
La Belle Associates 14-Feb-2017 Buyout/LBO Other Commercial Products 0000 0000
To view PanTheryx’s complete investments history, request access »

PanTheryx Subsidiaries (2)

Company Name Industry Location Founded
La Belle Associates Other Commercial Products Bellingham, WA 1984
0000000000 Other Consumer Non-Durables FL
To view PanTheryx’s complete subsidiaries history, request access »